Key result
Unfractionated heparin remains the standard procedural anticoagulant during PCI, but a review of its role and dosage is overdue as current dose selection is heavily influenced by tradition.
A review of unfractionated heparin dosing during percutaneous coronary intervention is needed to re-evaluate traditional practices.
Answers are grounded in this paper and cite their sources.
Traditional UFH dosing in PCI may reflect tradition over evidence; leaves open whether updated trials can optimize regimens.
Despite dramatic advances in percutaneous coronary intervention, including coronary stents and potent antiplatelet agents, unfractionated heparin remains the standard procedural anticoagulant. Tradition and habit may have considerable influence over dose selection. A review of the role and dosage of heparin during PCI appears to be overdue
No takes yet. Share an insight, caveat, or question.
Giampaolo Niccoli (2002) studied this question. Unfractionated heparin remains the standard procedural anticoagulant during PCI, but a review of its role and dosage is overdue as current dose selection is heavily influenced by tradition.
Synapse has enriched 10 related papers. Consider them for comparative context: